{"id":53698,"date":"2023-09-20T09:49:34","date_gmt":"2023-09-20T09:49:34","guid":{"rendered":"https:\/\/medsname.com\/vorier\/"},"modified":"2026-04-30T10:25:10","modified_gmt":"2026-04-30T10:25:10","slug":"vorier","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/vorier\/","title":{"rendered":"Vorier"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 20px;margin:18px 0;border-radius:6px;\">\n<h3 style=\"margin-top:0;\">\ud83d\udca1 R\u0103spuns rapid<\/h3>\n<p style=\"margin-bottom:0;\">Vorier este un comprimat oral de voriconazol 200 mg \u2014 un triazol de genera\u021bia a doua \u0219i <strong>tratament de prim\u0103 linie pentru aspergiloza invaziv\u0103<\/strong>. Acoper\u0103, de asemenea, Candida (inclusiv unele tulpini rezistente la fluconazol), Scedosporium, Fusarium. Medicament ini\u021biat \u00een spital \u2014 este necesar monitorizarea concentra\u021biei minime (TDM) (1\u20135,5 mg\/L), evaluare oftalmologic\u0103 de baz\u0103 obligatorie (tulbur\u0103ri vizuale frecvente) \u0219i monitorizare frecvent\u0103 a func\u021biei hepatice. Farmacocinetica extrem de complex\u0103: neliniar\u0103 (polimorfism CYP2C19), inhibitor puternic al CYP3A4, fotosensibilitate \u2192 risc de cancer de piele la utilizare pe termen lung.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f5f5f5;border:1px solid #e1e1e1;padding:18px 22px;margin:24px 0;border-radius:8px;display:flex;flex-wrap:wrap;justify-content:space-around;gap:16px;align-items:center;font-size:0.95em;\">\n<div style=\"text-align:center;flex:1;min-width:140px;\">\ud83c\udfed<br \/><strong>WHO-GMP<\/strong><br \/>produc\u0103tor autorizat<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<div style=\"text-align:center;flex:1;min-width:140px;\">\ud83d\udce6<br \/><strong>Ambalaj discret<\/strong><br \/>plic simplu<\/div>\n<div style=\"text-align:center;flex:1;min-width:140px;\">\ud83c\udf0d<br \/><strong>Livrare \u00een toat\u0103 lumea<\/strong><br \/>\u00een majoritatea \u021b\u0103rilor<\/div>\n<div style=\"text-align:center;flex:1;min-width:140px;\">\u2b50<br \/><strong>peste 1.400 de clien\u021bi<\/strong><br \/><a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">cite\u0219te recenziile<\/a><\/div>\n<\/div>\n<h2>\ud83d\udd12 De ce s\u0103 comanzi Vorier de la MedsBase<\/h2>\n<ul>\n<li><strong>produc\u0103tor certificat WHO-GMP<\/strong> \u2014 provenit de la o unitate reglementat\u0103, ambalaj final cu num\u0103r de lot \u0219i dat\u0103 de expirare.<\/li>\n<li><strong>Ambalaj discret<\/strong> \u2014 plic simplu, f\u0103r\u0103 denumirea medicamentului pe exterior.<\/li>\n<li><strong>Livrare \u00een toat\u0103 lumea<\/strong> \u00een majoritatea \u021b\u0103rilor cu <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a>.<\/li>\n<li><strong>Puncte de loialitate<\/strong> \u2014 1 punct pentru fiecare 1$ cheltuit (excluz\u00e2nd peptidele\/transportul); 100 puncte = 5$ reducere la urm\u0103toarea comand\u0103.<\/li>\n<\/ul>\n<h2 id=\"uses\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<p>Vorier (voriconazol 200 mg, Glenmark) este un antifungic specializat \u2014 de prim\u0103 linie pentru aspergiloza invaziv\u0103 (stabilit \u00een studiul Herbrecht 2002 NEJM), \u0219i o op\u021biune pentru candidoza invaziv\u0103, infec\u021bii cu Scedosporium \u0219i Fusarium, candidoza esofagian\u0103 refractar\u0103 la fluconazol \u0219i neutropenie febril\u0103 \u00een cazuri selectate. <strong>Nu este un medicament de prim\u0103 linie pentru candidoza vaginal\u0103, candidoza oral\u0103 sau onicomicoz\u0103<\/strong> \u2014 utiliza\u021bi fluconazol sau terbinafin\u0103 pentru acestea.<\/p>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;font-size:0.95em;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ccc;\">Indica\u021bie<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ccc;\">Regim tipic<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Aspergiloza invaziv\u0103<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Doza de \u00eenc\u0103rcare IV 6 mg\/kg la 12 ore \u00d7 24 h, apoi 4 mg\/kg la 12 ore IV; sau oral 200 mg la 12 ore (\u2265 40 kg) \/ 100 mg la 12 ore (&lt; 40 kg)<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Candidoz\u0103 (la pacien\u021bi non-neutropenici)<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Aceea\u0219i dozare \u2014 minim 14 zile dup\u0103 prima hemocultur\u0103 negativ\u0103<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Candidoza esofagian\u0103 (refractar\u0103 la fluconazol)<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">200 mg la 12 ore \u00d7 14\u201321 zile<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Infec\u021bie cu Scedosporium \/ Fusarium<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">200 mg la 12 ore, durata \u00een func\u021bie de r\u0103spuns<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Terapie empiric\u0103 \u00een neutropenie febril\u0103<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">200 mg la fiecare 12 ore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"how-to-take\">Cum se administreaz\u0103<\/h2>\n<ul>\n<li>Lua\u021bi 1 or\u0103 \u00eenainte sau 1 or\u0103 dup\u0103 o mas\u0103 \u2014 alimentele reduc absorb\u021bia cu ~22%.<\/li>\n<li>\u00cenghi\u021bi\u021bi \u00eentreaga tablet\u0103 cu ap\u0103.<\/li>\n<li>Doza de \u00eenc\u0103rcare este critic\u0103 \u2014 f\u0103r\u0103 ea, starea sta\u021bionar\u0103 este atins\u0103 \u00een 5\u20137 zile.<\/li>\n<li>Monitorizarea terapeutic\u0103 a medicamentului (nivel minim 1\u20135,5 mg\/L) la ziua 5\u20137 \u0219i dup\u0103 modificarea dozei.<\/li>\n<\/ul>\n<h2 id=\"mechanism\">Cum func\u021bioneaz\u0103<\/h2>\n<p>Voriconazolul inhib\u0103 CYP51 fungic cu o afinitate mai mare dec\u00e2t fluconazolul, extinz\u00e2nd acoperirea la Aspergillus \u0219i majoritatea Candida non-albicans. Farmacocinetica este neliniar\u0103 la adul\u021bi \u2014 mici modific\u0103ri ale dozei provoac\u0103 schimb\u0103ri mari ale concentra\u021biei. Polimorfismul CYP2C19: metabolizatorii slabi (15% din asiaticii de est, 3% din caucazieni) au niveluri de 4 ori mai mari; metabolizatorii ultra-rapizi pot s\u0103 nu ating\u0103 niveluri terapeutice. <strong>Acesta este motivul pentru care monitorizarea terapeutic\u0103 a medicamentului este obligatorie.<\/strong><\/p>\n<h2 id=\"side-effects\">Efecte secundare \u0219i monitorizare<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;font-size:0.95em;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ccc;\">Frecven\u021b\u0103<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ccc;\">Efecte<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Foarte frecvent<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\"><strong>Tulbur\u0103ri vizuale<\/strong> \u2014 vedere \u00eence\u021bo\u0219at\u0103, fotopsie, percep\u021bie alterat\u0103 a culorilor (~30%, mai ales \u00een prima s\u0103pt\u0103m\u00e2n\u0103, reversibil\u0103)<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Frecvente<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Eruptie cutanat\u0103, grea\u021b\u0103, v\u0103rs\u0103turi, dureri abdominale, diaree, edem periferic, febr\u0103, cre\u0219teri ale enzimelor hepatice<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Pu\u021bin frecvente<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Fotosensibilitate\/fototoxicitate, halucina\u021bii, confuzie, hipokalemie<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Rare, dar grave<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Hepatotoxicitate (inclusiv hepatit\u0103 fatale), prelungire QT\/torsade de pointes, SJS\/TEN, periostit\u0103 (pe termen lung \u2014 acumulare de fluorur\u0103), carcinom cu celule scuamoase la nivelul pielii (fotosensibilitate pe termen lung)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 20px;margin:20px 0;border-radius:6px;\"><strong>Avertisment privind cancerul de piele<\/strong><\/p>\n<div>Voriconazolul induce fotosensibilitate sever\u0103 \u0219i este asociat cu carcinomul cu celule scuamoase \u00een terapia cronic\u0103 (majoritatea cazurilor &gt; 6 luni de utilizare continu\u0103). Pacien\u021bii care folosesc voriconazol pe termen lung trebuie s\u0103 utilizeze zilnic protec\u021bie solar\u0103 cu SPF 50+ cu spectru larg, s\u0103 evite expunerea direct\u0103 la soare \u0219i s\u0103 efectueze screening dermatologic anual. Orice leziune nou\u0103 a pielii \u00eentr-o zon\u0103 expus\u0103 la soare = trimitere imediat\u0103 la dermatolog.<\/div>\n<\/div>\n<h2 id=\"interactions\">Interac\u021biuni medicamentoase \u2014 extinse<\/h2>\n<p>Voriconazolul este metabolizat de CYP2C19, CYP2C9, CYP3A4 \u2014 \u0219i este el \u00eensu\u0219i un puternic inhibitor al tuturor celor trei. Preocup\u0103ri majore:<\/p>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;font-size:0.95em;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ccc;\">Medicament<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ccc;\">Efect<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ccc;\">Ac\u021biune<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Rifampicin\u0103\/rifabutin\u0103\/carbamazepin\u0103\/fenobarbital<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Induc\u021bie puternic\u0103 \u2192 niveluri nedetectabile de voriconazol<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Contraindica\u021bii<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Iarba Sf\u00e2ntului Ioan<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Acela\u0219i efect de induc\u021bie<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Contraindica\u021bii<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Sirolimus<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Cre\u0219tere de 8\u00d7 \u2014 toxicitate sever\u0103<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Contraindica\u021bii<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Pimozid\u0103\/chinidin\u0103\/terfenadin\u0103\/cisaprid\u0103<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Prelungirea intervalului QT<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Contraindica\u021bii<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Alcaloizi ergot<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Vasoconstric\u021bie \u2192 ergotism<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Contraindica\u021bii<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Tacrolimus\/ciclosporin\u0103<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Cre\u0219tere de 2\u20133\u00d7<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Reduce\u021bi doza; monitorizare la valul minim<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Warfarin<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Cre\u0219tere INR<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Monitorizare str\u00e2ns\u0103 a INR<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Statine (simvastatin\u0103, atorvastatin\u0103)<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Risc de rabdomioliz\u0103<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">\u00centrerupe\u021bi sau trece\u021bi la pravastatin\u0103<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Fenitoin\u0103<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Bidirec\u021bional \u2014 nivelurile de voriconazol scad, nivelurile de fenitoin\u0103 cresc<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Evita\u021bi; dac\u0103 se utilizeaz\u0103, cre\u0219te\u021bi voriconazolul cu 100% \u0219i monitoriza\u021bi fenitoina<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Omeprazol \/ esomeprazol<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Nivelurile de PPI cresc; efect modest asupra voriconazolului<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">\u00cenjum\u0103t\u0103\u021bi\u021bi doza de PPI<\/td>\n<\/tr>\n<tr style=\"background:#fff;\">\n<td style=\"padding:8px;border:1px solid #ccc;\">Metadon\u0103, opioide<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Cre\u0219terea depresiei SNC<\/td>\n<td style=\"padding:8px;border:1px solid #ccc;\">Reduce\u021bi doza de opioide<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"monitoring\">Monitorizare obligatorie<\/h2>\n<ul>\n<li><strong>Monitorizarea terapeutic\u0103 a medicamentului<\/strong> \u2014 nivel plasmatic minim la ziua 5\u20137 \u0219i dup\u0103 fiecare modificare de doz\u0103. \u021aint\u0103 1,0\u20135,5 mg\/L (unele laboratoare 2,0\u20135,5 pentru aspergiloza invaziv\u0103).<\/li>\n<li><strong>Func\u021bia hepatic\u0103<\/strong> \u2014 valoare de baz\u0103, apoi s\u0103pt\u0103m\u00e2nal timp de 2\u20134 s\u0103pt\u0103m\u00e2ni, apoi lunar \u00een timpul terapiei.<\/li>\n<li><strong>Func\u021bie vizual\u0103<\/strong> \u2014 oftalmologie de baz\u0103 dac\u0103 terapia este preconizat\u0103 s\u0103 dureze &gt; 28 de zile.<\/li>\n<li><strong>Func\u021bia renal\u0103<\/strong> \u2014 forma IV con\u021bine ciclodextrin\u0103; evita\u021bi la CrCl &lt; 50, cu excep\u021bia cazurilor \u00een care beneficiul dep\u0103\u0219e\u0219te clar riscul (forma oral\u0103 este acceptabil\u0103).<\/li>\n<li><strong>Piele \/ dermatologie<\/strong> \u2014 evaluare anual\u0103 \u00een cazul terapiei pe termen lung.<\/li>\n<\/ul>\n<h2 id=\"contraindications\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Concomitent cu rifampicin\u0103, rifabutin\u0103, carbamazepin\u0103, fenobarbital, sun\u0103toare.<\/li>\n<li>Concomitent cu pimozid\u0103, chinidin\u0103, terfenadin\u0103, cisaprid\u0103, alcaloizi ai ergotului, sirolimus.<\/li>\n<li>Sarcin\u0103 (teratogenitate).<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103.<\/li>\n<li>Hipersensibilitate la alte azole.<\/li>\n<\/ul>\n<h2 id=\"pregnancy\">Sarcina &amp; al\u0103ptare<\/h2>\n<p>Voriconazolul este teratogen la animale \u0219i contraindicated \u00een sarcin\u0103, cu excep\u021bia cazurilor de micoze sistematice care pun via\u021ba \u00een pericol. Este necesar\u0103 contracep\u021bia eficient\u0103. Excre\u021bia \u00een laptele matern este necunoscut\u0103 \u2014 se prefer\u0103 alternative \u00een timpul al\u0103pt\u0103rii.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>V\u0103d sc\u00e2ntei de lumin\u0103 c\u00e2nd iau voriconazol \u2014 este normal?<\/h3>\n<p>Da \u2014 tulbur\u0103rile vizuale (fotopsie, vedere \u00eence\u021bo\u0219at\u0103, percep\u021bie alterat\u0103 a culorilor) apar la ~30% din pacien\u021bi, de obicei \u00een primele 2 ore de la administrare \u0219i se rezolv\u0103 \u00een c\u00e2teva zile p\u00e2n\u0103 la s\u0103pt\u0103m\u00e2ni, chiar \u0219i cu terapia continuat\u0103. Nu conduce\u021bi noaptea p\u00e2n\u0103 c\u00e2nd efectul nu este clar. Dac\u0103 sunt severe sau persistente, cere\u021bi monitorizarea terapeutic\u0103 a medicamentului (TDM) \u2014 nivelurile ridicate la trough agraveaz\u0103 simptomele.<\/p>\n<h3>De ce toat\u0103 lumea este at\u00e2t de \u00eengrijorat\u0103 de statutul meu CYP2C19?<\/h3>\n<p>Voriconazolul este metabolizat de CYP2C19. Metabolizatorii slabi (15% din popula\u021bia asiatic\u0103, 3% din popula\u021bia caucazian\u0103) au o expunere de 4 ori mai mare la dozele standard \u2192 toxicitate. Metabolizatorii ultra-rapizi pot s\u0103 nu ating\u0103 niveluri terapeutice \u2192 e\u0219ec terapeutic. Testarea farmacogenetic\u0103 sau simpla monitorizare terapeutic\u0103 a medicamentului (TDM) la ziua 5\u20137 rezolv\u0103 aceast\u0103 problem\u0103.<\/p>\n<h3>Pot trece de la voriconazol IV la administrare oral\u0103?<\/h3>\n<p>Da \u2014 odat\u0103 ce pacientul este stabil \u0219i tolereaz\u0103 administrarea oral\u0103. Biodisponibilitatea oral\u0103 este de ~96% la adul\u021bi, a\u0219adar doza r\u0103m\u00e2ne aceea\u0219i (200 mg la fiecare 12 ore pentru adul\u021bi \u2265 40 kg).<\/p>\n<h3>Ce protec\u021bie solar\u0103 ar trebui s\u0103 folosesc?<\/h3>\n<p>SPF 50+ cu spectru larg, minim, zilnic, inclusiv \u00een zilele \u00eennorate. Reaplica\u021bi la fiecare 2 ore c\u00e2nd sunte\u021bi \u00een exterior. \u00cembr\u0103c\u0103minte cu protec\u021bie UV cu m\u00e2neci lungi pentru expunere prelungit\u0103. Evita\u021bi complet paturile de bronzare.<\/p>\n<h3>Ce sunt \u2018periostita\u2019 \u0219i \u2018toxicitatea cu fluorur\u0103\u2019?<\/h3>\n<p>Voriconazolul con\u021bine fluorur\u0103. Terapia pe termen lung (luni) poate provoca periostit\u0103 dureroas\u0103 cu fosfataz\u0103 alcalin\u0103 \u0219i fluorur\u0103 seric\u0103 ridicate. Scanarea osoas\u0103 arat\u0103 captare. Se rezolv\u0103 la \u00eentreruperea tratamentului. Durere osoas\u0103 neexplicat\u0103 nou\u0103 pe terapia pe termen lung \u2014 verifica\u021bi ALP \u0219i fluorura seric\u0103.<\/p>\n<h3>Voriconazolul este acela\u0219i lucru cu Vfend?<\/h3>\n<p>Da \u2014 Vfend este marca original\u0103 Pfizer. Vorier con\u021bine acela\u0219i ingredient activ, fabricat de Glenmark sub WHO-GMP. Bioechivalent.<\/p>\n<h3>De ce specialistul meu \u00een onihomicoz\u0103 nu folose\u0219te voriconazol?<\/h3>\n<p>Voriconazolul este rezervat pentru micoze sistematice invazive. Pentru infec\u021bia unghial\u0103 cu dermatofite (cauza comun\u0103), terbinafina 250 mg\/zi \u00d7 12 s\u0103pt\u0103m\u00e2ni este de prim\u0103 inten\u021bie \u2014 rata de vindecare mai bun\u0103, mai pu\u021bine interac\u021biuni, mult mai ieftin\u0103. Voriconazolul ar fi utilizat doar pentru mucegaiuri neobi\u0219nuite (Scedosporium, Fusarium) confirmate prin cultur\u0103.<\/p>\n<h3>Ce se \u00eent\u00e2mpl\u0103 dac\u0103 am hepatit\u0103 \u00een timp ce iau voriconazol?<\/h3>\n<p>\u00centrerupe\u021bi voriconazolul dac\u0103 AST\/ALT &gt; 5\u00d7 ULN, sau orice cre\u0219tere + simptome (icter, urin\u0103 \u00eenchis\u0103, durere \u00een cadranul superior drept). Trece\u021bi la o alternativ\u0103 (caspofungin\u0103\/micafungin\u0103\/amfotericina B\/posaconazol\/isavuconazol, \u00een func\u021bie de indica\u021bie). Reintroducerea este uneori posibil\u0103 la doze mai mici, cu monitorizare atent\u0103.<\/p>\n<h3>Pot lua voriconazol cu inhibitori de pomp\u0103 de protoni (PPI)?<\/h3>\n<p>Voriconazolul inhib\u0103 CYP2C19, cresc\u00e2nd nivelurile de omeprazol \u0219i esomeprazol de ~2\u00d7. \u00cenjum\u0103t\u0103\u021bi\u021bi doza de PPI dac\u0103 continua\u021bi tratamentul. Pantoprazolul \u0219i rabeprazolul sunt mai pu\u021bin afecta\u021bi. Interac\u021biunea nu modific\u0103 semnificativ nivelurile de voriconazol.<\/p>\n<h3>Ce este monitorizarea terapeutic\u0103 a medicamentului (TDM) \u0219i de ce s\u0103pt\u0103m\u00e2nal la \u00eenceput?<\/h3>\n<p>Monitorizarea terapeutic\u0103 a medicamentului \u2014 m\u0103surarea nivelului plasmatic minim de voriconazol. \u021aint\u0103: 1\u20135,5 mg\/L. Sub 1: risc de e\u0219ec terapeutic. Peste 5,5: hepatotoxicitate, encefalopatie, probleme vizuale. Polimorfismul CYP2C19 face r\u0103spunsul la doz\u0103 impredictibil, a\u0219adar TDM este obligatoriu pentru aspergiloza invaziv\u0103.<\/p>\n<h2 id=\"storage\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi comprimatele la 15\u201330 \u00b0C \u00een ambalajul original. Proteja\u021bi de lumin\u0103. Nu folosi\u021bi dup\u0103 data de expirare. Nu l\u0103sa\u021bi la \u00eendem\u00e2na copiilor.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte medicamente antifungice care te-ar putea interesa<\/h2>\n<p>Voriconazolul este o terapie specializat\u0103. Mai jos sunt enumerate \u2014 aceea\u0219i molecul\u0103 de la un alt produc\u0103tor, plus antifungice de prim\u0103 linie pentru indica\u021biile comune unde voriconazolul este excesiv.<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/zocon\/\"><strong>Zocon (fluconazol 150 mg)<\/strong><\/a> \u2014 Prima linie pentru Candida non-Aspergillus; bine tolerat.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/sporanox-capsule\/\"><strong>Sporanox (itraconazol 100 mg)<\/strong><\/a> \u2014 Pentru micoze dimorfice + mucegaiuri non-Aspergillus.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/zimig\/\"><strong>Zimig (terbinafin\u0103 250 mg)<\/strong><\/a> \u2014 Infec\u021bii dermatofite ale unghiei\/pielii (nu mucegaiuri invazive).<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/clocip\/\"><strong>Clocip (clotrimazol 1%)<\/strong><\/a> \u2014 Candida topic\u0103, tineea dermatofit\u0103.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/loceryl-nail-liq\/\"><strong>Loceryl (amorolfin\u0103 5%)<\/strong><\/a> \u2014 Lac pentru unghii \u00een caz de onihomicoz\u0103 u\u0219oar\u0103.<\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 18px;margin:24px 0;font-size:0.95em;\"><strong>Not\u0103 medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 con\u021bine informa\u021bii despre produse pentru adul\u021bi care comand\u0103 medicamente antifungice pentru uz personal. Nu \u00eenlocuie\u0219te sfatul medical individual. Discut\u0103 cu un clinician calificat despre antifungicul potrivit, doza \u0219i durata tratamentului \u2014 mai ales dac\u0103 ai probleme hepatice, e\u0219ti gravid\u0103 sau al\u0103ptezi, iei warfarin, iei un statin, iei imunosupresoare sau ai o infec\u021bie fungic\u0103 la unghii care ar putea fi o alt\u0103 afec\u021biune (psoriazis, lichen planus, traumatism).<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Rapid\u0103 ameliorare a infec\u021biei fungice<br \/>\n\u2705 Eradicare eficient\u0103 a ciupercilor<br \/>\n\u2705 Verificat de exper\u021bi \u0219i de \u00eencredere<br \/>\n\u2705 Bine tolerat, efecte comune<br \/>\n\u2705 Administrare convenabil\u0103 a dozei<\/h5>\n<p><span style=\"color: #999999;\">Vorier con\u021bine Voriconazol<\/span><\/p>","protected":false},"featured_media":53699,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3501,3141,3504,3342],"product_tag":[],"class_list":{"0":"post-53698","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-fungal","7":"product_cat-category-overview","8":"product_cat-fungal-infection-treatment","9":"product_cat-general-health","11":"first","12":"outofstock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/53698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=53698"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/53699"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=53698"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=53698"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=53698"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=53698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}